Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

被引：0
作者：
Mallucci, G.
La Mantia, L.
Confalonieri, P. A.
Galgani, S.
Haggiag, S.
Lugaresi, A.
De Luca, G.
Solaro, C.
Trabucco, E.
Meola, G.
Robotti, M.
Cavaletti, G.
Frigeni, B.
Clerici, R.
Chiveri, L.
Bono, G.
Banfi, P.
Ambrosoni, E.
Mancardi, L.
Della Cava, F.
Balgera, R.
Bergamaschi, R.
机构：
[1] Fdn Ist Neurol Nazl C Mondino IRCCS, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Azienda Osped San Camillo Forlanini, Rome, Italy
[4] Policlin SS Annunziata, Chieti, Italy
[5] ASL3 Genovese, Genoa, Italy
[6] IRCCS Policlin San Donato, Milan, Italy
[7] Azienda Osped San Gerardo, Monza, Italy
[8] Osped Valduce, Como, Italy
[9] Osped Circolo Varese, Varese, Italy
[10] Fdn Macchi, Varese, Italy
[11] IRCCS Azienda Osped Univ San Martino, Genoa, Italy
[12] Azienda Osped Prov Lecco, Lecce, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
[31]   The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment [J].
Messina, Silvia ;
Patti, Francesco .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) :1349-1359
[32]   Glatiramer Acetate Depot (extended-release) phase IIa study in patients with Primary Progressive Multiple Sclerosis: safety and efficacy snapshot [J].
Flechter, Shlomo ;
Popper, Laura ;
Demender, Inna ;
Kimelman, Nadav Bleich ;
Rubnov, Shai ;
Danon, Uri ;
Marom, Ehud ;
Milo, Ron ;
Gilad, Ronit ;
Weller, Boaz ;
Vaknin-Dembinsky, Adi ;
Hellmann, Mark ;
Karni, Arnon .
NEUROLOGY, 2021, 96 (15)
[33]   Economic impact of glatiramer acetate in multiple sclerosis [J].
Ollendorf, DA ;
Jilinskaia, E ;
Oleen-Burkey, M .
VALUE IN HEALTH, 2002, 5 (06) :510-511
[34]   Glatiramer acetate: Mechanisms of action in multiple sclerosis [J].
Schrempf, Wiebke ;
Ziemssen, Tjalf .
AUTOIMMUNITY REVIEWS, 2007, 6 (07) :469-475
[35]   Glatiramer acetate therapy for multiple sclerosis: a review [J].
Perumal, Jai ;
Filippi, Massimo ;
Ford, Corey ;
Johnson, Kenneth ;
Lisak, Robert ;
Metz, Luanne ;
Tselis, Alexandros ;
Tullman, Mark ;
Khan, Omar .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) :1019-1029
[36]   Mechanisms of action of glatiramer acetate in multiple sclerosis [J].
Neuhaus, O ;
Farina, C ;
Wekerle, H ;
Hohlfeld, R .
NEUROLOGY, 2001, 56 (06) :702-708
[37]   Sublingual Immunotherapy for Allergic Respiratory Diseases: Efficacy and Safety [J].
Passalacqua, Giovanni ;
Canonica, Giorgio Walter .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2011, 31 (02) :265-+
[38]   Effects of glatiramer acetate therapy on metabolic markers in multiple sclerosis patients [J].
Montella, S. ;
Petracca, M. ;
Matarese, G. ;
Carbone, F. ;
La Rocca, C. ;
Carrieri, P. .
JOURNAL OF NEUROLOGY, 2011, 258 :206-207
[39]   Treatment with glatiramer acetate (Copaxone®) prevents neurodegeneration in patients with multiple sclerosis [J].
Jaworski, J. ;
Leinhard, O. Dahlqvist ;
Tisell, A. ;
Lundberg, P. ;
Landtblom, A. M. .
MULTIPLE SCLEROSIS, 2009, 15 (09) :S140-S141
[40]   Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients [J].
Ganji, Ali ;
Monfared, Mohsen Ebrahimi ;
Shapoori, Shima ;
Nourbakhsh, Parisa ;
Ghazavi, Ali ;
Ghasami, Keyvan ;
Mosayebi, Ghasem .
CYTOKINE, 2020, 126
12345